Stonebridge Capital Management »

Regeneron Pharmaceuticals shares owned by Stonebridge Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Stonebridge Capital Management from 13F filings

Historical chart of Stonebridge Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Stonebridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Stonebridge Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $707k 735 961.90
2023-12-31 $646k 735 878.91
2023-09-30 $605k 735 823.13
2023-06-30 $535k 745 718.12
2023-03-31 $612k 745 821.48
2022-12-31 $538k 745 722.15
2022-09-30 $634k 920 689.13
2022-06-30 $544k 920 591.30
2022-03-31 $643k 920 698.91
2021-12-31 $581k 920 631.52
2021-09-30 $556k 920 604.48
2021-06-30 $514k 920 558.21
2021-03-31 $435k 920 473.13
2020-12-31 $445k 920 483.58
2020-09-30 $515k 920 559.70
2020-06-30 $560k 920 608.96
2020-03-31 $474k 970 488.71
2019-12-31 $384k 1.0k 376.12
2019-09-30 $304k 1.1k 277.85
2019-06-30 $445k 1.4k 313.38
2019-03-31 $887k 2.2k 410.83
2018-12-31 $907k 2.2k 404.27
2018-09-30 $907k 2.2k 404.27
2018-06-30 $902k 2.5k 361.06
2018-03-31 $751k 2.3k 321.67
2017-12-31 $634k 1.7k 366.83